Skip to main content

Cancer Moonshot℠ Seminar Series

This seminar series showcases research from different Cancer Moonshot initiatives that support the 10 recommendations of the Blue Ribbon Panel report. These presentations will inform the community about the progress of Cancer Moonshot–funded projects, provide outreach related to Cancer Moonshot projects, enhance discussions and collaborations related to Cancer Moonshot research, and promote the sharing of data from Cancer Moonshot initiatives. 

Upcoming Events

Headshot of Katia Rebola and Frank Szulzewsky

December 15, 2022, 12:00–1:00 pm ET [Junior Investigator Session]

Theme: Molecular Dissection of Tumor Biology
Speakers: Katia Rebola, Ph.D., Oregon Health and Sciences University; Frank Szulzewsky, Ph.D., Fred Hutchison Cancer Center
Recommendations: Develop Ways to Overcome Cancer’s Resistance to Therapy and Intensify Research on the Major Drivers of Childhood Cancers

 

 

Headshot of Heidi Hanson


January 26, 2023, 12:00–1:00 pm ET

Title: DOE-NCI Collaboration: MOSSAIC for Advancing Computational Models for Cancer Research
Speaker: Heidi Hanson, Ph.D., Oak Ridge National Laboratory
Recommendation: Build a National Cancer Data Ecosystem

 

 

 

 

February 23, 2023, 12:00–1:00 pm ET [Junior Investigator Session]

Title: Advancing Cancer Outcomes through Implementation Science and Participant Engagement
Speakers: Bethany Davis, Ph.D., Translational Genomics Research Institute; Rebecca Smith, Dartmouth College
Recommendation: Minimize Cancer Treatment's Debilitating Side Effects and Establish a Network for Direct Patient Engagement

 

 

 

 

Headshot of Sandro Santagata


March 23, 2023, 12:00–1:00 pm ET

Title: Pre-Cancer Atlases of Cutaneous and Hematologic Origin
Speaker: Sandro Santagata, M.D., Ph.D., Brigham and Women’s Hospital
Recommendation: Generate Human Tumor Atlases

 

 

 

 

Headshot of Keith Syson Chan


April 27, 2023, 12:00–1:00 pm ET

Title: A Vicious Cycle of Pyroptotic Cancer Cells and Fibroblasts Fuels Chemoresistance
Speaker: Keith Syson Chan, Ph.D., Cedars-Sinai
Recommendation: Develop Ways to Overcome Cancer’s Resistance to Therapy

 

 

 

 

Headshot of Nikhil Wagle, M.D. and Katherine Janeway, M.D.

May 25, 2023, 12:00–1:00 pm ET

Title: Count Me In: Partnering with Patients to Define the Landscape of Rare, Aggressive Sarcomas
Speakers: Nikhil Wagle, M.D., Dana-Farber Cancer Institute; Katherine Janeway, M.D., Dana-Farber Cancer Institute
Recommendation: Establish a Network for Direct Patient Engagement

 

 

 

Headshot of Richard W. Kriwacki, Ph.D.

June 22, 2023, 12:00–1:00 pm ET

Title: The Molecular Role of NUP-98 Fusion Oncoproteins in Pediatric Leukemias
Speaker: Richard Kriwacki, Ph.D., St. Jude Children’s Research Hospital
Recommendation: Intensify Research on the Major Drivers of Childhood Cancers

 

 

 

 

 

Headshots of A.J. Robert McCray Ph.D. and Mark Yarmarkovich Ph.D.

July 27, 2023, 12:00–1:00 pm ET [Junior Investigator Session]

Theme: Improving Immunotherapy Strategies for Cancers
Speakers: A.J. Robert McCray, Ph.D., Roswell Park Cancer Center; Mark Yarmarkovich, Ph.D., Children’s Hospital of Philadelphia
Recommendations: Create an Adult Immunotherapy Network and Build a Pediatric Immunotherapy Discovery and Development Network

 

 

Past Seminars

Visit the Cancer Moonshot Seminar Series YouTube playlist to watch previous seminars.
Headshot of Zeynep Gümüş

November 17, 2022, 12:00–1:00 pm ET

**Joint Seminar for the Cancer Moonshot Seminar Series, NCI Emerging Technologies Seminar Series, and DataViz + Cancer

Title: Development of a Visualization Approach to Enhance Cancer Moonshot Data
Speaker: Zeynep Gümüş Ph.D., Icahn School of Medicine at Mt. Sinai
Recommendation: Develop New Enabling Cancer Technologies

 

 

How to Visually Explore Cancer-Omics Datasets?

Headshot of Shawn Demehri, M.D., Ph.D.

September 22, 2022, 12:00–1:00 pm ET

Title: The Role of Epithelium-Derived Alarmins in Breast Cancer Immunoprevention
Speaker: Shawn Demehri, M.D., Ph.D., Massachusetts General Hospital
Recommendation: Create an Adult Immunotherapy Network

 

The Role of Epithelium-Derived Alarmins in Breast Cancer Immunoprevention

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Cancer Moonshot℠ Seminar Series was originally published by the National Cancer Institute.”